FDA clears bioMerieux's MRSA test

05/25/2011 | MedCityNews.com

The FDA has granted bioMerieux 510(k) clearance to market NucliSENS EasyQ MRSA, a molecular test that can spot seven types of methicillin-resistant Staphylococcus aureus. The test can process up to 46 samples and generate results in three hours.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ